Anaptysbio

Forecast & Rating11 analysts currently cover Anaptysbio, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $87.09, about 60.8% upside from the current price of $54.15. Price targets range from $70.00 to $140.00 — a wide spread, showing clear disagreement over just how much Anaptysbio can rise. Historically, about 81.6% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Anaptysbio closely still see room for the stock to rise. Data as of Jul 25, 2026; for reference only and not investment advice.